Biopharmaceutical companies are beginning to explore quantum computing for solving complex research problems that are intractable with classical methods. This nascent technology holds promise for enhancing drug discovery, molecular simulation, and optimization tasks. Industry analyses suggest that quantum computing could accelerate innovation and provide competitive advantages in biopharma pipelines as the technology matures.